$SGRY
Surgery Partners, Inc. Stock $sgry

$sgry Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000163883320000058 Filed on August 05, 2020

Income Statement

Concept	2020 Q2	2019 Q2
Revenue	$374.7M	$445.4M
YoY Change	-15.87%	2.02%
Cost Of Revenue	$297.8M	$340.4M
YoY Change	-12.51%	0.09%
Gross Profit	$76.90M	$105.0M
YoY Change	-26.76%	8.81%
Gross Profit Margin	20.52%	23.57%
Selling, General & Admin	$46.80M	$44.30M
YoY Change	5.64%	-7.52%
% of Gross Profit	60.86%	42.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$23.40M	$19.10M
YoY Change	22.51%	14.37%
% of Gross Profit	30.43%	18.19%
Operating Expenses	$330.0M	$389.9M
YoY Change	-15.36%	-0.81%
Operating Profit	$44.70M	$55.50M
YoY Change	-19.46%	27.59%
Interest Expense	-$49.20M	-$46.40M
YoY Change	6.03%	29.25%
% of Operating Profit	-110.07%	-83.6%
Other Income/Expense, Net	$200.0K	$400.0K
YoY Change	-50.0%	-81.82%
Pretax Income	-$4.500M	$9.100M
YoY Change	-149.45%	19.74%
Income Tax	-$600.0K	$1.000M
% Of Pretax Income		10.99%
Net Earnings	-$32.50M	-$19.80M
YoY Change	64.14%	1.54%
Net Earnings / Revenue	-8.67%	-4.45%
Basic Earnings Per Share	-$0.86	-$0.59
Diluted Earnings Per Share	-$0.86	-$0.59
COMMON SHARES
Basic Shares Outstanding	48.84M shares	48.29M shares
Diluted Shares Outstanding	48.84M shares	48.29M shares

Balance Sheet

Concept	2020 Q2	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$326.3M	$117.4M
YoY Change	177.94%	22.16%
Cash & Equivalents	$326.3M	$117.4M
Short-Term Investments
Other Short-Term Assets	$37.00M	$55.70M
YoY Change	-33.57%	2.77%
Inventory	$49.00M	$44.00M
Prepaid Expenses	$23.30M
Receivables	$310.9M	$301.9M
Other Receivables	$8.200M	$10.00M
Total Short-Term Assets	$746.5M	$529.0M
YoY Change	41.12%	11.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$816.0M	$685.1M
YoY Change	19.11%	66.33%
Goodwill	$3.409B	$3.402B
YoY Change	0.19%	0.77%
Intangibles		$53.60M
YoY Change		-12.73%
Long-Term Investments	$91.40M	$93.70M
YoY Change	-2.45%	19.97%
Other Assets	$21.70M	$313.0M
YoY Change	-93.07%	507.99%
Total Long-Term Assets	$4.498B	$4.362B
YoY Change	3.12%	6.1%
TOTAL ASSETS
Total Short-Term Assets	$746.5M	$529.0M
Total Long-Term Assets	$4.498B	$4.362B
Total Assets	$5.245B	$4.891B
YoY Change	7.23%	6.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$104.7M	$71.70M
YoY Change	46.03%	-5.86%
Accrued Expenses	$258.6M	$222.3M
YoY Change	16.33%	60.97%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$63.50M	$57.30M
YoY Change	10.82%	-4.98%
Total Short-Term Liabilities	$571.2M	$368.8M
YoY Change	54.88%	24.27%
LONG-TERM LIABILITIES
Long-Term Debt	$2.623B	$2.397B
YoY Change	9.39%	6.4%
Other Long-Term Liabilities	$127.3M	$387.1M
YoY Change	-67.11%	57.19%
Total Long-Term Liabilities	$127.3M	$387.1M
YoY Change	-67.11%	57.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$571.2M	$368.8M
Total Long-Term Liabilities	$127.3M	$387.1M
Total Liabilities	$698.5M	$755.9M
YoY Change	-7.59%	39.2%
SHAREHOLDERS EQUITY
Retained Earnings		-$268.9M
YoY Change		243.43%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$204.4M	$358.7M
YoY Change
Total Liabilities & Shareholders Equity	$5.245B	$4.891B
YoY Change	7.23%	6.7%

Cashflow Statement

Concept	2020 Q2	2019 Q2
OPERATING ACTIVITIES
Net Income	-$32.50M	-$19.80M
YoY Change	64.14%	1.54%
Depreciation, Depletion And Amortization	$23.40M	$19.10M
YoY Change	22.51%	14.37%
Cash From Operating Activities	$181.9M	$26.70M
YoY Change	581.27%	-32.41%
INVESTING ACTIVITIES
Capital Expenditures	-$8.100M	-$20.00M
YoY Change	-59.5%	238.98%
Acquisitions
YoY Change
Other Investing Activities	-$6.700M	-$4.500M
YoY Change	48.89%	-64.0%
Cash From Investing Activities	-$14.80M	-$24.50M
YoY Change	-39.59%	33.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-35.40M	-27.30M
YoY Change	29.67%	-28.16%
NET CHANGE
Cash From Operating Activities	181.9M	26.70M
Cash From Investing Activities	-14.80M	-24.50M
Cash From Financing Activities	-35.40M	-27.30M
Net Change In Cash	131.7M	-25.10M
YoY Change	-624.7%	48.52%
FREE CASH FLOW
Cash From Operating Activities	$181.9M	$26.70M
Capital Expenditures	-$8.100M	-$20.00M
Free Cash Flow	$190.0M	$46.70M
YoY Change	306.85%	2.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001638833
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37576
	dei	Entity Registrant Name EntityRegistrantName	Surgery Partners, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3620923
	dei	Entity Address Address Line1 EntityAddressAddressLine1	310 Seven Springs Way, Suite 500
	dei	Entity Address City Or Town EntityAddressCityOrTown	Brentwood
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37027
	dei	City Area Code CityAreaCode	615
	dei	Local Phone Number LocalPhoneNumber	234-5900
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	SGRY
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50551483	shares
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	326300000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92700000	USD
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	310900000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	326900000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	49000000.0	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	46300000	USD
CY2020Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	23300000	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	17800000	USD
CY2020Q2	us-gaap	Other Assets Current OtherAssetsCurrent	37000000.0	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	41800000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	746500000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	525500000	USD
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	152000000.0	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	110700000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	504300000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	523300000	USD
CY2020Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3454600000	USD
CY2019Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3449700000	USD
CY2020Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	91100000	USD
CY2019Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	93200000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	311700000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	297700000	USD
CY2020Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	114800000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	98700000	USD
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21700000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	30800000	USD
CY2020Q2	us-gaap	Assets Assets	5244700000	USD
CY2019Q4	us-gaap	Assets Assets	5018900000	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	104700000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	96700000	USD
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	57900000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	54200000	USD
CY2020Q2	sgry	Medicare Accelerated Payments And Deferred Governmental Grants Current MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent	124700000	USD
CY2019Q4	sgry	Medicare Accelerated Payments And Deferred Governmental Grants Current MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent	0	USD
CY2020Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	220400000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	191200000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	63500000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	56000000.0	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	571200000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	398100000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2622500000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2524700000	USD
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	298900000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	283100000	USD
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	127300000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	113600000	USD
CY2020Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	314700000	USD
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	321000000.0	USD
CY2020Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	310000	shares
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	310000	shares
CY2019Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	310000	shares
CY2019Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	310000	shares
CY2020Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	310000	shares
CY2019Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	310000	shares
CY2020Q2	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Redemption Value RedeemableNoncontrollingInterestEquityPreferredRedemptionValue	414200000	USD
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Redemption Value RedeemableNoncontrollingInterestEquityPreferredRedemptionValue	395000000.0	USD
CY2020Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	414200000	USD
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	395000000.0	USD
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2020Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50551483	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50551483	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49298940	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49298940	shares
CY2020Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	500000	USD
CY2019Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	500000	USD
CY2020Q2	sgry	Other Stockholders Equity Attributable To Parent OtherStockholdersEquityAttributableToParent	203900000	USD
CY2019Q4	sgry	Other Stockholders Equity Attributable To Parent OtherStockholdersEquityAttributableToParent	296300000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	204400000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	296800000	USD
CY2020Q2	us-gaap	Minority Interest MinorityInterest	691500000	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	686600000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	895900000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	983400000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5244700000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5018900000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	374700000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	445400000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	815700000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	862200000	USD
CY2020Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	116100000	USD
CY2019Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	132700000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	256500000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	261900000	USD
CY2020Q2	us-gaap	Supplies Expense SuppliesExpense	110100000	USD
CY2019Q2	us-gaap	Supplies Expense SuppliesExpense	123400000	USD
	us-gaap	Supplies Expense SuppliesExpense	239400000	USD
	us-gaap	Supplies Expense SuppliesExpense	238400000	USD
CY2020Q2	us-gaap	Professional Fees ProfessionalFees	45300000	USD
CY2019Q2	us-gaap	Professional Fees ProfessionalFees	36400000	USD
	us-gaap	Professional Fees ProfessionalFees	92100000	USD
	us-gaap	Professional Fees ProfessionalFees	71500000	USD
CY2020Q2	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	21500000	USD
CY2019Q2	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	21000000.0	USD
	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	42800000	USD
	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	41600000	USD
CY2020Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	26300000	USD
CY2019Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	26900000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	54700000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	53100000	USD
CY2020Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	319300000	USD
CY2019Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	340400000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	685500000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	666500000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25300000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23300000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48100000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	45000000.0	USD
CY2020Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23400000	USD
CY2019Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19100000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45200000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37900000	USD
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2500000	USD
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2200000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4500000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4200000	USD
CY2020Q2	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-2900000	USD
CY2019Q2	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	8200000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-6400000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	7600000	USD
CY2020Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	4900000	USD
CY2019Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	6200000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	10400000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	8200000	USD
CY2020Q2	sgry	Grant Revenue GrantRevenue	43100000	USD
CY2019Q2	sgry	Grant Revenue GrantRevenue	0	USD
CY2020Q2	sgry	Grant Revenue GrantRevenue	43100000	USD
	sgry	Grant Revenue GrantRevenue	43100000	USD
	sgry	Grant Revenue GrantRevenue	0	USD
CY2020Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2019Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1200000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11700000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11700000	USD
CY2020Q2	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-200000	USD
CY2019Q2	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-400000	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-1700000	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-400000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	330000000.0	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	389900000	USD
	us-gaap	Operating Expenses OperatingExpenses	747500000	USD
	us-gaap	Operating Expenses OperatingExpenses	757100000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	44700000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	55500000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	68200000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	105100000	USD
CY2020Q2	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	0	USD
CY2019Q2	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	0	USD
	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	0	USD
	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	2400000	USD
CY2020Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-49200000	USD
CY2019Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-46400000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-96300000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-88400000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4500000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	9100000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-28100000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	14300000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-600000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000000.0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15800000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2700000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-3900000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	8100000	USD
	us-gaap	Profit Loss ProfitLoss	-12300000	USD
	us-gaap	Profit Loss ProfitLoss	11600000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	28600000	USD
CY2019Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	27900000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	47700000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	51500000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-32500000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-19800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-60000000.0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-39900000	USD
CY2020Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	9700000	USD
CY2019Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	8800000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	19200000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	17300000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-42200000	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28600000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-79200000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-57200000	USD
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.63
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.19
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.19
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48840000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48291000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48661000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48241000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48840000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48291000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48661000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48241000	shares
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-3900000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	8100000	USD
	us-gaap	Profit Loss ProfitLoss	-12300000	USD
	us-gaap	Profit Loss ProfitLoss	11600000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	7300000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-16800000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-17900000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-28300000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3400000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-8700000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-30200000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-16700000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	28600000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	27900000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	47700000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	51500000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25200000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36600000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-77900000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-68200000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1098900000	USD
CY2019Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-4100000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	900000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	8500000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-11500000	USD
CY2019Q1	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	14100000	USD
CY2019Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	23500000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1084300000	USD
CY2019Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-1100000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3100000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	8800000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-16800000	USD
CY2019Q2	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	2000000.0	USD
CY2019Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	17700000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1045000000.0	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	983400000	USD
CY2020Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-13900000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2800000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	9500000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-25200000	USD
CY2020Q1	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	700000	USD
CY2020Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	14900000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	923400000	USD
CY2020Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-9700000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3800000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	9700000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	7300000	USD
CY2020Q2	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	1700000	USD
CY2020Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	20900000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	895900000	USD
	us-gaap	Profit Loss ProfitLoss	-12300000	USD
	us-gaap	Profit Loss ProfitLoss	11600000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45200000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37900000	USD
	sgry	Noncash Interest Income Expense Net NoncashInterestIncomeExpenseNet	-2200000	USD
	sgry	Noncash Interest Income Expense Net NoncashInterestIncomeExpenseNet	-100000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6900000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4900000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-6400000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	7600000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11700000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16400000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2000000.0	USD
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	200000	USD
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-100000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	20100000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	19600000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-16300000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6900000	USD
	sgry	Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants	124700000	USD
	sgry	Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants	0	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-18200000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	40000000.0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	211100000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	47200000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19900000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31800000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	12400000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	13200000	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	9400000	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	17600000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	15200000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-400000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	300000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22500000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42900000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	182800000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	422800000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	288200000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	438900000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6500000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	8800000	USD
	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	0	USD
	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	17800000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	51700000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	60900000	USD
	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-1900000	USD
	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	1200000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-300000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000.0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	45000000.0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-71200000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	233600000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-66900000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93000000.0	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184600000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	326600000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117700000	USD
CY2020Q2	sgry	Number Of Surgical Facilities Owned NumberOfSurgicalFacilitiesOwned	127	surgical_facility
CY2020Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	30	state
CY2020Q2	sgry	Number Of Surgical Facilities Owned Majority Interest NumberOfSurgicalFacilitiesOwnedMajorityInterest	85	surgical_facility
CY2020Q2	sgry	Number Of Surgical Facilities Owned Consolidated NumberOfSurgicalFacilitiesOwnedConsolidated	107	surgical_facility
	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-indent:18pt;text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div>
	sgry	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	48000000	USD
CY2020Q2	sgry	Grant Revenue GrantRevenue	43100000	USD
	sgry	Grant Revenue GrantRevenue	43100000	USD
	sgry	Coronavirus Aid Reliefand Economic Security Act Cares Act Government Grant Received Accelerated Payments CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments	120000000	USD
CY2020Q2	sgry	Deferred Employee Related Liabilities Current DeferredEmployeeRelatedLiabilitiesCurrent	4300000	USD
CY2020Q2	sgry	Variable Interest Entity Number Of Facilities VariableInterestEntityNumberOfFacilities	4	surgical_facility
CY2020Q2	sgry	Variable Interest Entity Number Of Facilities VariableInterestEntityNumberOfFacilities	3	Anesthesia_Practice
CY2020Q2	sgry	Variable Interest Entity Number Of Facilities VariableInterestEntityNumberOfFacilities	3	physician_practice
CY2020Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	68600000	USD
CY2019Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	50700000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	374700000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	445400000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	815700000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	862200000	USD
CY2020Q2	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	300000	USD
CY2019Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	300000	USD
CY2020Q2	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	13000000.0	USD
CY2019Q4	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	5600000	USD
CY2020Q2	sgry	Optical Products Receivable OpticalProductsReceivable	8200000	USD
CY2019Q4	sgry	Optical Products Receivable OpticalProductsReceivable	8600000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	3402400000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	20700000	USD
	sgry	Goodwill Written Off Related To Sale Of Business Unit And Deconsolidations GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidations	14200000	USD
CY2020Q2	us-gaap	Goodwill Goodwill	3408900000	USD
CY2019Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	316000000.0	USD
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	321000000.0	USD
CY2018Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	326600000	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	11300000	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	16800000	USD
	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	-1700000	USD
	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	-7700000	USD
	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	15900000	USD
	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	19700000	USD
CY2020Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	314700000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.562
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.189
	sgry	Effective Income Tax Rate Reconciliation Coronavirus Aid Reliefand Economic Security Act Cares Act EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefandEconomicSecurityActCARESAct	6900000	USD
	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	5000000.0	USD
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	3	surgery_center
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	2000000.0	USD
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.24
CY2020Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	244100000	USD
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	253400000	USD
CY2020Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	16600000	USD
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	10800000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	2686000000.0	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	2580700000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	63500000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	56000000.0	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2622500000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2524700000	USD
	sgry	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	23200000	USD
CY2020Q2	sgry	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	23200000	USD
	sgry	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	23200000	USD
CY2020Q2	sgry	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	23200000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	36300000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	34400000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	12000000.0	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	9300000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	10400000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	7300000	USD
	sgry	Finance Lease Cost FinanceLeaseCost	22400000	USD
	sgry	Finance Lease Cost FinanceLeaseCost	16600000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	8300000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	6000000.0	USD
	us-gaap	Lease Cost LeaseCost	67000000.0	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	9100000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-28100000	USD
	us-gaap	Lease Cost LeaseCost	57000000.0	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	33700000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	32800000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	10400000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	7300000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8300000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5200000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	37500000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5000000.0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	8500000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	5000000.0	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	26900000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	31100000	USD
CY2020Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2019Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	21700000	USD
CY2020Q2	us-gaap	Number Of Interest Rate Derivatives Held NumberOfInterestRateDerivativesHeld	4	swap
CY2020Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-1700000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	18300000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	5600000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	1500000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	9000000.0	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	2800000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-32500000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-19800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-60000000.0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-39900000	USD
CY2020Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	9700000	USD
CY2019Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	8800000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	19200000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	17300000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-42200000	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28600000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-79200000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-57200000	USD
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48840000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48291000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48661000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48241000	shares
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.86
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.59
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.63
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.19
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37800000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37300000	USD
CY2020Q2	us-gaap	Litigation Reserve Current LitigationReserveCurrent	32300000	USD
CY2019Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	35100000	USD
CY2020Q2	us-gaap	Interest Payable Current InterestPayableCurrent	22000000.0	USD
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	21800000	USD
CY2020Q2	srt	Payables To Customers PayablesToCustomers	19700000	USD
CY2019Q4	srt	Payables To Customers PayablesToCustomers	16500000	USD
CY2020Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	108600000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	80500000	USD
CY2020Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	220400000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	191200000	USD
CY2020Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	21000000.0	USD
CY2019Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	19400000	USD
CY2020Q2	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	12100000	USD
CY2019Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	12100000	USD
CY2020Q1	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	40000000.0	USD
CY2020Q1	sgry	Litigation Settlement Interest Percentage LitigationSettlementInterestPercentage	0.0275
CY2020Q1	sgry	Litigation Settlement Amount Awardedfrom Other Party Approved Paid Claims LitigationSettlementAmountAwardedfromOtherPartyApprovedPaidClaims	7500000	USD
CY2020Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	1800000	USD
CY2018	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-46000000.0	USD
CY2020Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1200000	USD
	sgry	Collaborative Tax Agreement Projected Tax Savings Term CollaborativeTaxAgreementProjectedTaxSavingsTerm	P5Y
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	815700000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	862200000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4500000	USD
CY2020Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	60100000	USD
CY2019Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	60100000	USD
CY2020Q2	sgry	Deferred Income Tax Liabilities Net Of Discount DeferredIncomeTaxLiabilitiesNetOfDiscount	51200000	USD
CY2019Q4	sgry	Deferred Income Tax Liabilities Net Of Discount DeferredIncomeTaxLiabilitiesNetOfDiscount	48700000	USD
CY2019Q4	sgry	Deferred Income Tax Liabilities Net Of Discount Current DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent	16900000	USD
CY2020Q2	sgry	Deferred Income Tax Liabilities Net Of Discount Current DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent	16900000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	374700000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	445400000	USD
CY2020Q2	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	58200000	USD
CY2019Q2	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	61200000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	104700000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	112000000.0	USD
CY2019Q2	sgry	Business Combination Gain Loss On Acquisition Escrow BusinessCombinationGainLossOnAcquisitionEscrow	0	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-96300000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4900000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	14300000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	28600000	USD
CY2019Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	27900000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	47700000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	51500000	USD
CY2020Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23400000	USD
CY2019Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19100000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45200000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37900000	USD
CY2020Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-49200000	USD
CY2019Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-46400000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-88400000	USD
CY2020Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3400000	USD
CY2019Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3000000.0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6900000	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11700000	USD
CY2020Q2	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	10100000	USD
CY2019Q2	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	8000000.0	USD
	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	22700000	USD
	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	11500000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11700000	USD
CY2020Q2	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-2900000	USD
CY2019Q2	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	8200000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-6400000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	7600000	USD
CY2020Q2	sgry	Gain Loss Relatedto Litigation Settlement And Other Litigation Costs GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts	2300000	USD
CY2019Q2	sgry	Gain Loss Relatedto Litigation Settlement And Other Litigation Costs GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts	0	USD
	sgry	Gain Loss Relatedto Litigation Settlement And Other Litigation Costs GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts	3800000	USD
	sgry	Gain Loss Relatedto Litigation Settlement And Other Litigation Costs GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts	0	USD
CY2020Q2	sgry	Business Combination Gain Loss On Acquisition Escrow BusinessCombinationGainLossOnAcquisitionEscrow	0	USD
CY2020Q2	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	0	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	112000000.0	USD
CY2020Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	4900000	USD
CY2019Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	6200000	USD
	sgry	Business Combination Gain Loss On Acquisition Escrow BusinessCombinationGainLossOnAcquisitionEscrow	-800000	USD
	sgry	Business Combination Gain Loss On Acquisition Escrow BusinessCombinationGainLossOnAcquisitionEscrow	0	USD
CY2019Q2	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	0	USD
	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	0	USD
	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	2400000	USD
CY2020Q2	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	58200000	USD
CY2019Q2	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	61200000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	104700000	USD
CY2020Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5200000	USD
CY2019Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1800000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	10400000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	8200000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	12300000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3300000	USD
CY2020Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	2300000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1200000	USD
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	2600000	USD
CY2020Q2	us-gaap	Assets Assets	5244700000	USD
CY2019Q4	us-gaap	Assets Assets	5018900000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19900000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31800000	USD

Files In Submission

Name	View Source	Status
0001638833-20-000058-index-headers.html	Edgar Link	pending
0001638833-20-000058-index.html	Edgar Link	pending
0001638833-20-000058.txt	Edgar Link	pending
0001638833-20-000058-xbrl.zip	Edgar Link	pending
a2020q2exhibit101.htm	Edgar Link	pending
a2020q2exhibit102.htm	Edgar Link	pending
a2020q2exhibit311.htm	Edgar Link	pending
a2020q2exhibit312.htm	Edgar Link	pending
a2020q2exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgry-20200630.htm	Edgar Link	pending
sgry-20200630.xsd	Edgar Link	pending
sgry-20200630_cal.xml	Edgar Link	unprocessable
sgry-20200630_def.xml	Edgar Link	unprocessable
sgry-20200630_htm.xml	Edgar Link	completed
sgry-20200630_lab.xml	Edgar Link	unprocessable
sgry-20200630_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGRY
Surgery Partners, Inc. Stock $sgry

2020 Q2 Form 10-Q Financial Statement

#000163883320000058 Filed on August 05, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY Surgery Partners, Inc. Stock $sgry

2020 Q2 Form 10-Q Financial Statement

#000163883320000058 Filed on August 05, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY
Surgery Partners, Inc. Stock $sgry